ePlus (PLUS) director awarded 1,478 restricted shares at $0
ePlus Inc. (PLUS) reported an insider equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ePlus Inc. (PLUS) reported an insider equity grant. A director acquired 1,478 shares of common stock on 10/01/2025 as a restricted stock award under the company’s 2024 Non-Employee Director Long Term Incentive Plan. The grant price was $0.
The restricted shares are subject to a restriction period ending on the first anniversary of the grant, with potential lapse or forfeiture under the plan’s terms. After the transaction, the director beneficially owns 13,838 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,478 | $0.00 | $0.00 |
Footnotes (1)
- F1. This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant (the "Restriction Period"). As more fully described in the Plan, under certain other circumstances the restrictions may lapse, or the shares may be forfeited and transferred back to the Company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ePlus (PLUS) disclose in this Form 4?
What plan governed the ePlus (PLUS) restricted stock grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.